VALSCOPE
日本米国
codese.net

RESMED INC

RMDUS
SEC EDGARで開く
売上高
$5.1B
百万USD
営業利益
$1.7B
百万USD
純利益
$1.4B
百万USD
ROE
23.5%
最新FY
EPS
$9.51
USD / 株
配当
$2.12
USD / 株

業績推移

収益性

キャッシュフロー

財務状況

四半期業績

年度売上高純利益EPS
FY2021Q1$752M$178M$1.22
FY2021Q2$800M$180M$1.23
FY2021Q3$769M$-78M$-0.54
FY2021FY$3.2B$475M$3.24
FY2022Q1$904M$204M$1.39
FY2022Q2$895M$202M$1.37
FY2022Q3$865M$179M$1.22
FY2022FY$3.6B$779M$5.30
FY2023Q1$950M$210M$1.43
FY2023Q2$1.0B$225M$1.53
FY2023Q3$1.1B$233M$1.58
FY2023FY$4.2B$898M$6.09
FY2024Q1$1.1B$219M$1.49
FY2024Q2$1.2B$209M$1.42
FY2024Q3$1.2B$300M$2.04
FY2024FY$4.7B$1.0B$6.92
FY2025Q1$1.2B$311M$2.11
FY2025Q2$1.3B$345M$2.34
FY2025Q3$1.3B$365M$2.48
FY2025FY$5.1B$1.4B$9.51
FY2026Q1$1.3B$349M$2.37
FY2026Q2$1.4B$393M$2.68
FY2026Q3$1.4B$399M$2.74

財務データ

指標FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
売上高---$2.6B$3.0B$3.2B$3.6B$4.2B$4.7B$5.1B
営業利益$429M$426M$542M$579M$810M$904M$1.0B$1.1B$1.3B$1.7B
純利益$352M$342M$316M$405M$622M$475M$779M$898M$1.0B$1.4B
総資産$3.3B$3.5B$3.1B$4.1B$4.6B$4.7B$5.1B$6.8B$6.9B$8.2B
純資産----------
自己資本$1.7B$2.0B$2.1B$2.1B$2.5B$2.9B$3.4B$4.1B$4.9B$6.0B
営業CF--$505M$459M$802M$737M$351M$693M$1.4B$1.8B
EPS$2.49$2.40$2.19$2.80$4.27$3.24$5.30$6.09$6.92$9.51
BPS$12.05$13.78$14.43$14.42$17.23$19808.20$22.95$28.08$33.10$40.76
ROE20.8%17.5%15.3%19.5%24.9%16.4%23.2%21.7%21.0%23.5%
RESMED INC(RMD)の業績・財務推移 | Valscope